Capacity of endometrial thickness measurement to diagnose endometrial carcinoma in asymptomatic postmenopausal women: a systematic review and meta-analysis

07.12.2021 - 16:03 43
Capacity of endometrial thickness measurement to diagnose endometrial carcinoma in asymptomatic postmenopausal women: a systematic review and meta-analysis

Dan Su1,2, Ling Li2,3, Min Zhong2,4, Yidan Xia1,2

  • 1Department of Gynecology and Obstetrics, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, China;
  • 2Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, China;
  • 3 Department of Ultrasound, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, China;
  • 4 Department of Operating Room, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, China

Background: Endometrial thickness (ET) is closely related to many gynecological symptoms. The measurement of ET is also an important tool for evaluating adverse symptoms such as bleeding in postmenopausal women. However, the significance of ET in asymptomatic women is still unclear. The purpose of this study was to determine the correlation between ET and the incidence of endometrial lesions in asymptomatic women after menopause, and to statistically analyze the correlation with a 5 mm cutoff value

Methods: A systematic literature search was conducted in May 2021 to screen out articles that reported that ET measurement was used to diagnose endometrial carcinoma (EC), endometrial hyperplasia (EH), and endometrial polyps (EP) in asymptomatic postmenopausal women who did not use hormone replacement therapy (HRT). The endometrial membrane was set at 5 mm as the cut-off, and using 5 mm as the cut-off of the ET, the relationship between the thickness of the endometrium and the prevalence of EC, EH, and EP was evaluated. Relative risk (RR) and standardized mean difference (SMD) were extrapolated with 95% confidence interval (CI).

Results: After screening, 9 studies reported a total of 3,620 cases of asymptomatic postmenopausal women whose ET was measured. Among them, there were 1,758 cases of ET <5 mm, the probability of EC, EH, and EP were 0.284% (5/1,758), 0.398% (7/1,758), and 0.626% (11/1,758), respectively. In another 1,862 cases with ET ≥5 mm, the probabilities of EC, EH, and EP were 1.128% (21/1,862), 1.128% (21/1,862), and 1.557% (29/1,862), respectively. The results showed that ET can be used as a risk factor for predicting EC and other pathological changes.

Discussion: The results of this meta-analysis show that when the ET is greater than 5 mm, the incidence of EC, EH, and EP increases significantly. It is reasonable to use ET as a screening test for EC and EH in asymptomatic postmenopausal women.

Keywords: Endometrial carcinoma (EC); endometrial thickness (ET); endometrial hyperplasia (EH); asymptomatic postmenopausal women; meta-analysis 

Download


Тематики

Тематики гинекологии Бесплодие Дисменорея Материнская смертность Новости российской медицины Беременность Воспалительные заболевания Вульвовагинальные заболевания Генетика Грудное вскармливание Дети Исследование Контрацепция Материнская смертность Миома матки Менопауза Недержание мочи Онкология Мастопатия Нормативно-правовая документация Пролапс тазовых органов Рак эндометрия Рак шейки матки Рак груди Рак яичников Роды Сахарный диабет Урогенитальные инфекции Цистит Хирургия ЭКО Эндометриоз Тяжелый случай Урологическая интернет-конференция №8 «Аккредитация, НМО, личный бренд и юридическая грамотность» Материалы конгрессов Российская научно-практическая конференция с межд. участием «Снегиревские чтения» II Региональный научно-образовательный форум акушеров-гинекологов Час с ведущим гинекологом Мастер-класс «Тазовая хирургия: реальность и перспективы» I Международный конгресс "Патология шейки матки, влагалища и вульвы"